Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment-Reference-Cited by-同舟云学术

Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment

Published:2020-02-06 Issue:6 Volume:27 Page:568-575
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Liu Chen‐Hua¹²³^ORCID,Yang Sheng‐Shun⁴⁵⁶⁷⁸,Peng Cheng‐Yuan⁹¹⁰^ORCID,Lin Woan‐Tyy⁴,Liu Chun‐Jen¹²¹¹,Su Tung‐Hung¹²,Tseng Tai‐Chung¹²,Chen Pei‐Jer¹²¹¹,Chen Ding‐Shinn¹²¹²,Kao Jia‐Horng¹²¹¹^ORCID

Affiliation:

1. Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan

2. Hepatitis Research Center National Taiwan University Hospital Taipei Taiwan

3. Department of Internal Medicine National Taiwan University Hospital Yun‐Lin Branch, Douliou Taiwan

4. Division of Gastroenterology and Hepatology Department of Internal Medicine Taichung Veterans General Hospital Taichung Taiwan

5. School of Medicine Chung Shan Medical University Taichung Taiwan

6. Rong Hsing Research Center for Translational Medicine National Chung Hsing University Taipei Taiwan

7. Ph.D. Program in Translational Medicine National Chung Hsing University Taichung Taiwan

8. Institute of Biomedical Sciences National Chung Hsing University Taichung Taiwan

9. Center for Digestive Medicine Department of Internal Medicine China Medical University Hospital Taichung Taiwan

10. School of Medicine China Medical University Taichung Taiwan

11. Graduate Institute of Clinical Medicine National Taiwan University College of Medicine Taipei Taiwan

12. Genomics Research Center Academia Sinica Taipei Taiwan

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13265

Reference48 articles.

1. A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease

2. Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis

3. Treatment of hepatitis C virus infection in patients with end-stage renal disease

4. Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study

5. Kidney Function Decline in Patients with CKD and Untreated Hepatitis C Infection

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review;Expert Opinion on Pharmacotherapy;2024-08-12

2. The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis;Frontiers in Public Health;2023-09-29

3. Diagnosis, Prevention, and Treatment of Infections in Kidney Transplantation;Seminars in Nephrology;2023-09

4. Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection;Journal of Clinical Medicine;2023-03-03

5. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02